NICE drafts guidance recommending siponimod to treat secondary progressive multiple sclerosis

multiple sclerosis

NICE has issued draft guidance that now recommends siponimod for treating secondary progressive multiple sclerosis

Please register to continue reading this content

Register for free

Guidelines is completely free for UK-based doctors, nurses, and pharmacists